MicroSectors FANG and Innovation 3X Leveraged ETN vs Altria Group Inc — how do they compare? MicroSectors FANG and Innovation 3X Leveraged ETN trades at $32.69, while Altria Group Inc trades at $65.16 (market cap $114.13B). The key difference: Altria Group Inc pays a 6.2% dividend while MicroSectors FANG and Innovation 3X Leveraged ETN pays none, and MicroSectors FANG and Innovation 3X Leveraged ETN is trading nearer its 52-week high, Altria Group Inc nearer its low. Which is the better fit depends on your goals.
| FNGU | MO | |
|---|---|---|
Sector | Leveraged / Inverse | Consumer Staples |
52-Week High | $36.15 | $74.92 |
52-Week Low | $13.73 | $54.72 |
Market Cap | — | $114.13B |
Enterprise Value | — | $136.34B |
Dividend Yield | — | 6.2% |
Signals from Pluang's Aura AI — not financial advice
FNGU, a leveraged ETN tracking the FANG+ Index, trades at $33.53, up 4.65% today. Technical indicators show a bullish trend with strong moving average support, though the 6-day RSI at 94.67 signals overbought conditions. Recent news highlights extreme volatility, with a 16% intraday drop reported on June 5, 2026, underscoring the inherent risks of leveraged products.
The outlook remains highly speculative, driven by tech sector momentum but tempered by structural decay risks from daily rebalancing. Key risks include amplified losses during market downturns and the product's design, which can erode value over time. Investors should weigh the potential for high returns against the possibility of rapid capital depletion.
Altria Group (MO) trades at $68.35, up 0.89% with mixed technical signals showing bearish moving averages but oversold RSI levels. The company maintains strong profitability with 39% net income margin and $6.95B net income for 2025, though revenue declined slightly to $20.14B. Recent earnings show alternating beats and misses, with Q3 2026 results pending. Analyst consensus remains bullish with 61.5% buy ratings and $71.50 price target, while the stock offers a 6.3% dividend yield with 56 consecutive annual increases expected.
MO presents value opportunity with 14.4x P/E ratio and strong cash flow generation, but faces headwinds from cigarette volume declines and regulatory pressures. The smoke-free product transition shows progress but remains early stage. Current price near support at $67 suggests limited downside, while analyst targets indicate 4.6% upside potential. Key risks include litigation exposure and slower-than-expected diversification from traditional tobacco products.
Trailing returns across standard periods
Latest headlines on both assets
FNGU is a leveraged ETN that seeks to provide three times (3x) the daily performance of top tech and innovation stocks. It is intended for traders seeking magnified short-term returns.
Read more on FNGU →Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).
Read more on MO →